Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 851 to 875 of 2524

TitleReference numberPublishedLast updated
Electrohydraulic lithotripsy for difficult-to-treat bile duct stonesIPG698
Ibrutinib with obinutuzumab for untreated chronic lymphocytic leukaemia and small lymphocytic lymphoma (terminated appraisal)TA702
Ibrutinib with rituximab for untreated chronic lymphocytic leukaemia (terminated appraisal)TA703
Trastuzumab deruxtecan for treating HER2-positive unresectable or metastatic breast cancer after 2 or more anti-HER2 therapiesTA704
Heavy menstrual bleeding: assessment and managementNG88
Ravulizumab for treating paroxysmal nocturnal haemoglobinuriaTA698
Ofatumumab for treating relapsing multiple sclerosisTA699
Crisaborole for treating mild to moderate atopic dermatitis in people 2 years and older (terminated appraisal)TA701
HeartFlow FFRCT for estimating fractional flow reserve from coronary CT angiographyHTG429
Parafricta Bootees and Undergarments to reduce skin breakdown in people with or at risk of pressure ulcersHTG355
KODEX-EPD for cardiac imaging during ablation of arrhythmiasMIB260
Permanent His-bundle pacemaker implantation for treating heart failureIPG694
Axonics sacral neuromodulation system for faecal incontinenceMIB259
UroLift for treating lower urinary tract symptoms of benign prostatic hyperplasiaHTG578
Repetitive short-pulse transscleral cyclophotocoagulation for glaucomaIPG692
Deep brain stimulation for chronic, severe, treatment-resistant obsessive-compulsive disorder in adultsIPG693
Pembrolizumab for treating locally advanced or metastatic urothelial carcinoma after platinum-containing chemotherapyTA692
Bempedoic acid with ezetimibe for treating primary hypercholesterolaemia or mixed dyslipidaemiaTA694
Carfilzomib with dexamethasone and lenalidomide for previously treated multiple myelomaTA695
Melphalan chemosaturation with percutaneous hepatic artery perfusion and hepatic vein isolation for primary or metastatic cancer in the liverIPG691
microINR for anticoagulation therapyMIB257
Acalabrutinib for treating chronic lymphocytic leukaemiaTA689
Avelumab for untreated metastatic Merkel cell carcinomaTA691
Avelumab for treating metastatic Merkel cell carcinomaTA517
Postnatal careNG194

Results per page

  1. 10
  2. 25
  3. 50
  4. All